CORRESP Filing
Werewolf Therapeutics, Inc.
Date: May 13, 2025 · CIK: 0001785530 · Accession: 0001193125-25-118796
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287078
Letter
Re: Werewolf Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-287078 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Werewolf Therapeutics, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287078), so that it may become effective at 4:00 p.m. Eastern time on May 15, 2025, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
WEREWOLF THERAPEUTICS, INC. 200 Talcott Avenue, 2 nd Floor Watertown, MA 02472 May 13, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes
Very truly yours,
WEREWOLF THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP WEREWOLF THERAPEUTICS, INC. 200 Talcott Avenue, 2 nd Floor Watertown, MA 02472 May 13, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: Werewolf Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-287078 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Werewolf Therapeutics, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287078), so that it may become effective at 4:00 p.m. Eastern time on May 15, 2025, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, WEREWOLF THERAPEUTICS, INC. By: /s/ Daniel J. Hicklin Name: Daniel J. Hicklin, Ph.D. Title: President and Chief Executive Officer cc: Rosemary G. Reilly Stephanie Leopold Wilmer Cutler Pickering Hale and Dorr LLP